QUIBIM is a medtech company specialising in Artificial Intelligence (AI) and image processing technologies applied to the development of imaging biomarkers in the medical imaging field. The company has a proprietary software platform QUIBIM Precision® and AI algorithms for quantitative imaging biomarkers used by hospitals, pharmaceutical companies and R&D centres.

The QUIBIM Precision® image analysis platform has received CE Mark certification as a Class IIa Medical Device, including its imaging biomarker analysis algorithms, the zero footprint DICOM viewer and its platform hosting these components and medical imaging data.

The company has offices in Valencia, Madrid and the USA. QUIBIM’s products are currently in use at over 70 sites, with more than 600,000 analyses performed and 6.5 million images analysed.

Amadeus contact

Pierre Socha